United States· US:84999-014_3a342660-e737-0d64-e063-6294a90a0e52
Schuessler Tissue Salts Calc Phos Bone Health 2
A medicinal product containing anhydrous dibasic calcium phosphate, registered in United States by Martin & Pleasance Pty Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ANHYDROUS DIBASIC CALCIUM PHOSPHATE
- Manufacturer
- Martin & Pleasance Pty Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184999-014-01
- ndc1184999014011 BOTTLE in 1 CARTON (84999-014-01) / 125 TABLET, CHEWABLE in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e65e6a88-c700-4c45-88e2-815458c74be1 GET /v1/drugs/e65e6a88-c700-4c45-88e2-815458c74be1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
"productndc": "84999-014",
"dosage_form": "TABLET, CHEWABLE",
"dea_schedule": null,
"strength_unit": "[hp_X]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about anhydrous dibasic calcium phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.